NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $330,321 | +25.6% | 35,749 | +11.0% | 0.08% | +11.3% |
| Q2 2022 | $263,000 | -8.7% | 32,209 | +281.2% | 0.07% | -28.3% |
| Q4 2021 | $288,000 | -36.6% | 8,450 | -64.4% | 0.10% | -42.1% |
| Q3 2019 | $454,000 | +80.9% | 23,731 | +107.4% | 0.17% | +50.0% |
| Q2 2019 | $251,000 | -48.6% | 11,442 | -52.0% | 0.11% | -52.5% |
| Q1 2019 | $488,000 | +80.7% | 23,862 | +15.7% | 0.24% | +15.4% |
| Q2 2018 | $270,000 | +92.9% | 20,627 | +20.4% | 0.21% | +76.3% |
| Q1 2018 | $140,000 | +52.2% | 17,127 | +64.3% | 0.12% | +73.5% |
| Q4 2017 | $92,000 | -61.7% | 10,427 | -51.6% | 0.07% | -64.9% |
| Q3 2017 | $240,000 | +103.4% | 21,544 | +64.0% | 0.19% | +76.4% |
| Q2 2017 | $118,000 | 0.0% | 13,140 | -12.5% | 0.11% | -63.9% |
| Q1 2017 | $118,000 | +1.7% | 15,009 | +10.4% | 0.30% | -14.8% |
| Q4 2016 | $116,000 | -3.3% | 13,590 | -6.9% | 0.36% | +10.8% |
| Q3 2016 | $120,000 | +17.6% | 14,603 | +14.7% | 0.32% | -37.4% |
| Q2 2016 | $102,000 | – | 12,736 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |